Trial Profile
Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs MCS 8 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 04 Dec 2015 New trial record